
Pfizer Asks FDA To Authorize COVID Vaccine For Children 5 to 11 After Positive Trials
Pfizer and BioNTech have asked the U.S. Food and Drug Administration to approve their COVID-19 vaccine for use in children ages 5 to 11, Pfizer announced this morning. If the FDA approves an emergency use authorization, it would be the first time a COVID-19 vaccine was available for children younger than 12.